INTRA-CELLULAR THERAPIES, INC.
Patent Owner
Stats
- 59 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Feb 15, 2018 most recent publication
Details
- 59 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 3,601 Total Citation Count
- Jun 06, 2006 Earliest Filing
- 6 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9801882 Phosphodiesterase-1 inhibitors and their use in treatment of cardiovascular diseasesFeb 17, 14Oct 31, 17[A61K]
9751883 Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofMar 10, 16Sep 05, 17[C07D]
9708322 Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activityMar 15, 14Jul 18, 17[A61K, C07D]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.